Related references
Note: Only part of the references are listed.An interactive web-based dashboard to track COVID-19 in real time
Ensheng Dong et al.
LANCET INFECTIOUS DISEASES (2020)
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Hao Xu et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2020)
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
Sangeun Jeon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Yixuan J. Hou et al.
CELL (2020)
Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic
Zahra Belhadjer et al.
CIRCULATION (2020)
Myocardial localization of coronavirus in COVID-19 cardiogenic shock
Guido Tavazzi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Children's heart and COVID-19: Up-to-date evidence in the form of a systematic review
Giulia Sanna et al.
EUROPEAN JOURNAL OF PEDIATRICS (2020)
Fatal Eosinophilic Myocarditis in a Healthy 17-Year-Old Male with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2c)
Randall Craver et al.
FETAL AND PEDIATRIC PATHOLOGY (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19
Hisashi Kai et al.
HYPERTENSION RESEARCH (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children
Marion Grimaud et al.
ANNALS OF INTENSIVE CARE (2020)
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
Meng-Yuan Li et al.
INFECTIOUS DISEASES OF POVERTY (2020)
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
Zou Xin et al.
FRONTIERS OF MEDICINE (2020)
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
Shaobo Shi et al.
JAMA CARDIOLOGY (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Multiorgan and Renal Tropism of SARS-CoV-2
Victor G. Puelles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
JAK inhibitors in COVID-19: the need for vigilance regarding increased inherent thrombotic risk
Puja Mehta et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
Ross W. Paterson et al.
BRAIN (2020)
Coronavirus Disease 2019 (COVID-19) and the Heart-Is Heart Failure the Next Chapter?
Clyde W. Yancy et al.
JAMA CARDIOLOGY (2020)
Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors
Timothy A. Yap et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies
Felicitas Escher et al.
ESC HEART FAILURE (2020)
Myocarditis in a 16-year-old boy positive for SARS-CoV-2
Massimiliano Gnecchi et al.
LANCET (2020)
Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial
Panagiotis A. Konstantinopoulos et al.
LANCET ONCOLOGY (2020)
Repurposing of Kinase Inhibitors for Treatment of COVID-19
Ellen Weisberg et al.
PHARMACEUTICAL RESEARCH (2020)
Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo
Stuart Weston et al.
JOURNAL OF VIROLOGY (2020)
SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome
Marisa Dolhnikoff et al.
LANCET CHILD & ADOLESCENT HEALTH (2020)
Direct Exposure to SARS-CoV-2 and Cigarette Smoke Increases Infection Severity and Alters the Stem Cell-Derived Airway Repair Response
Arunima Purkayastha et al.
CELL STEM CELL (2020)
Cerebral Micro-Structural Changes in COVID-19 Patients - An MRI-based 3-month Follow-up Study
Yiping Lu et al.
ECLINICALMEDICINE (2020)
Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3
Xue Lian et al.
JOURNAL OF VIROLOGY (2019)
Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy
Qiang Zhang et al.
CANCER RESEARCH (2019)
Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand
Lin Mei et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Axl Promotes Zika Virus Entry and Modulates the Antiviral State of Human Sertoli Cells
Daniel P. Strange et al.
MBIO (2019)
Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs
Stanford Schor et al.
DNA AND CELL BIOLOGY (2018)
Induction of autophagy by PI3K/MTOR and PI3K/MTOR/BRD4 inhibitors suppresses HIV-1 replication
Grant R. Campbell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors
Anish Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Nonstructural Protein 5A Impairs DNA Damage Repair: Implications for Hepatitis C Virus-Mediated Hepatocarcinogenesis
Tram T. T. Nguyen et al.
JOURNAL OF VIROLOGY (2018)
Take your PIKK: tumour viruses and DNA damage response pathways
Neha J. Pancholi et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication
Sharon K. Kuss-Duerkop et al.
PLOS PATHOGENS (2017)
Adapting the Stress Response: Viral Subversion of the mTOR Signaling Pathway
Valerie Le Sage et al.
VIRUSES-BASEL (2016)
Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation
David T. Coleman et al.
ONCOTARGET (2016)
Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities
Kumar Sanjiv et al.
CELL REPORTS (2016)
Activation of the DNA Damage Response by RNA Viruses
Ellis L. Ryan et al.
BIOMOLECULES (2016)
Targeting cancer with kinase inhibitors
Stefan Gross et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Viral DNA Replication-Dependent DNA Damage Response Activation during BK Polyomavirus Infection
Brandy Verhalen et al.
JOURNAL OF VIROLOGY (2015)
DYRK2 Negatively Regulates Type I Interferon Induction by Promoting TBK1 Degradation via Ser527 Phosphorylation
Tai An et al.
PLOS PATHOGENS (2015)
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
Julie Dyall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970
Amy B. Hall et al.
ONCOTARGET (2014)
The Human Adenovirus E4-ORF1 Protein Subverts Discs Large 1 to Mediate Membrane Recruitment and Dysregulation of Phosphatidylinositol 3-Kinase
Kathleen Kong et al.
PLOS PATHOGENS (2014)
Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells
Feng Lan et al.
CELL STEM CELL (2013)
A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents
Peter B. Madrid et al.
PLOS ONE (2013)
FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection
Lisa M. Johansen et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Hepatitis C Virus Activates the mTOR/S6K1 Signaling Pathway in Inhibiting IRS-1 Function for Insulin Resistance
Sandip K. Bose et al.
JOURNAL OF VIROLOGY (2012)
Phosphorylation events during viral infections provide potential therapeutic targets
Julie A. Keating et al.
REVIEWS IN MEDICAL VIROLOGY (2012)
Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy
Ning Sun et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Productive Replication of Ebola Virus Is Regulated by the c-Abl1 Tyrosine Kinase
Mayra Garcia et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Small-molecule protein kinase inhibitors and their effects on the immune system: implications for cancer treatment
Patrick A. Ott et al.
IMMUNOTHERAPY (2011)
Coronavirus Infection Induces DNA Replication Stress Partly through Interaction of Its Nonstructural Protein 13 with the p125 Subunit of DNA Polymerase δ
Ling Hui Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The DNA Damage Response Induces IFN
Sabrina Brzostek-Racine et al.
JOURNAL OF IMMUNOLOGY (2011)
Multiple DNA Damage Signaling and Repair Pathways Deregulated by Simian Virus 40 Large T Antigen
Sergei Boichuk et al.
JOURNAL OF VIROLOGY (2010)
A genome-wide genetic screen for host factors required for hepatitis C virus propagation
Qisheng Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein
Filippo Pacciarini et al.
JOURNAL OF VIROLOGY (2008)
Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening
Lubica Supekova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
STITCH: interaction networks of chemicals and proteins
Michael Kuhn et al.
NUCLEIC ACIDS RESEARCH (2008)
Using or abusing: viruses and the cellular DNA damage response
Caroline E. Lilley et al.
TRENDS IN MICROBIOLOGY (2007)
The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor
Akrit Sodhi et al.
CANCER CELL (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded LMP2A
CA Moody et al.
JOURNAL OF VIROLOGY (2005)
Share Paper
